总时间（秒）：12.92
问答时间（秒）：11.77

```json
{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "G4A",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 p.G2385R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates LRRK2 variants associated with Parkinson’s Disease (PD) and reports that LRRK2 mutations explain between 5 and 13% of familial and 1 and 5% of sporadic PD.  The research focuses on Chinese patients and identifies multiple LRRK2 variants that exert an individual effect and together modulate the risk of PD.",
          "judgment": "Yes",
          "reasoning": "The abstract clearly states the study's focus on LRRK2 variants and their contribution to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study examines dopaminergic neuronal lines, p.R1398H had significantly lower kinase activity, whereas p.G2385R and p.R1628P showed higher kinase activity than wild type.",
          "judgment": "Yes",
          "reasoning": "Kinase activity assays are a standard method for evaluating variant effects on protein function in PD research.",
          "next_step_or_outcome": "Proceed to Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The demonstration of altered kinase activity for p.G2385R and p.R1628P compared to wild type, coupled with the study's focus on LRRK2 variants and PD, supports a pathogenic role for these variants."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "G4C",
          "position": "1628"
        },
        "variant_string_id": "LRRK2 p.R1628P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates LRRK2 variants associated with Parkinson’s Disease (PD) and reports that LRRK2 mutations explain between 5 and 13% of familial and 1 and 5% of sporadic PD.  The research focuses on Chinese patients and identifies multiple LRRK2 variants that exert an individual effect and together modulate the risk of PD.",
          "judgment": "Yes",
          "reasoning": "The abstract clearly states the study’s focus on LRRK2 variants and their contribution to PD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study examines dopaminergic neuronal lines, p.R1398H had significantly lower kinase activity, whereas p.G2385R and p.R1628P showed higher kinase activity than wild type.",
          "judgment": "Yes",
          "reasoning": "Kinase activity assays are a standard method for evaluating variant effects on protein function in PD research.",
          "next_step_or_outcome": "Proceed to Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The demonstration of altered kinase activity for p.R1628P compared to wild type, coupled with the study’s focus on LRRK2 variants and PD, supports a pathogenic role for this variant."
    }
  ]
}
```